Cargando…

Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study

BACKGROUND: Heart failure is one of the most important complications of chronic kidney disease (CKD). However, few studies comprehensively investigated left ventricular (LV) structure and function in relation to 2 key CKD measures, estimated glomerular filtration rate (eGFR) and urine albumin/creati...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsushita, Kunihiro, Kwak, Lucia, Sang, Yingying, Ballew, Shoshana H., Skali, Hicham, Shah, Amil M., Coresh, Josef, Solomon, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634280/
https://www.ncbi.nlm.nih.gov/pubmed/28939714
http://dx.doi.org/10.1161/JAHA.117.006259
_version_ 1783270056550989824
author Matsushita, Kunihiro
Kwak, Lucia
Sang, Yingying
Ballew, Shoshana H.
Skali, Hicham
Shah, Amil M.
Coresh, Josef
Solomon, Scott
author_facet Matsushita, Kunihiro
Kwak, Lucia
Sang, Yingying
Ballew, Shoshana H.
Skali, Hicham
Shah, Amil M.
Coresh, Josef
Solomon, Scott
author_sort Matsushita, Kunihiro
collection PubMed
description BACKGROUND: Heart failure is one of the most important complications of chronic kidney disease (CKD). However, few studies comprehensively investigated left ventricular (LV) structure and function in relation to 2 key CKD measures, estimated glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (ACR). METHODS AND RESULTS: Among 4175 ARIC (Atherosclerosis Risk in Communities) participants (aged 66–90 years during 2011–2013), we quantified the association of eGFR and ACR with echocardiogram parameters of LV mass, size, systolic function, and diastolic function. Adjusting for demographic variables, both CKD measures were significantly associated with most echocardiogram parameters. Additionally accounting for other potential confounders, we observed significantly higher LV mass index according to reduced eGFR (82.3 [95% confidence interval (CI), 77.6–87.0] g/m(2) for eGFR <30 mL/min per 1.73 m(2), 80.9 [95% CI, 77.3–84.6] g/m(2) for eGFR 30–44 mL/min per 1.73 m(2), and 80.1 [95% CI, 76.7–83.5] g/m(2) for eGFR 45–59 mL/min per 1.73 m(2) compared with 78.7 [95% CI, 75.3–82.1] g/m(2) for eGFR 75–89 mL/min per 1.73 m(2); trend P<0.001). Regarding LV size and function, significant differences were observed for some parameters, particularly at eGFR <30 mL/min per 1.73 m(2). For ACR, the associations remained significant for most parameters (eg, LV mass index, 91.5 [95% CI, 86.6–96.5] g/m(2) for ACR ≥300 mg/g and 82.9 [95% CI, 79.4–86.3] g/m(2) for ACR 30–299 mg/g compared with 77.7 [95% CI, 74.4–81.1] g/m(2) for ACR <10 mg/g [trend P<0.001]; left arterial volume index, 24.9 [95% CI, 22.9–26.8] and 24.7 [95% CI, 23.4–26.1] mL/m(2) compared with 23.4 [95% CI, 22.1–24.7] mL/m(2), respectively [trend P=0.010]). Dichotomizing echo parameters with clinical thresholds, the stronger relationships of ACR over eGFR were further evident. CONCLUSIONS: LV mass was related to both CKD measures, whereas LV size and function were robustly associated with albuminuria. These results have implications for pathophysiological processes behind cardiorenal syndrome and targeted cardiac assessment in patients with CKD.
format Online
Article
Text
id pubmed-5634280
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56342802017-10-18 Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study Matsushita, Kunihiro Kwak, Lucia Sang, Yingying Ballew, Shoshana H. Skali, Hicham Shah, Amil M. Coresh, Josef Solomon, Scott J Am Heart Assoc Original Research BACKGROUND: Heart failure is one of the most important complications of chronic kidney disease (CKD). However, few studies comprehensively investigated left ventricular (LV) structure and function in relation to 2 key CKD measures, estimated glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (ACR). METHODS AND RESULTS: Among 4175 ARIC (Atherosclerosis Risk in Communities) participants (aged 66–90 years during 2011–2013), we quantified the association of eGFR and ACR with echocardiogram parameters of LV mass, size, systolic function, and diastolic function. Adjusting for demographic variables, both CKD measures were significantly associated with most echocardiogram parameters. Additionally accounting for other potential confounders, we observed significantly higher LV mass index according to reduced eGFR (82.3 [95% confidence interval (CI), 77.6–87.0] g/m(2) for eGFR <30 mL/min per 1.73 m(2), 80.9 [95% CI, 77.3–84.6] g/m(2) for eGFR 30–44 mL/min per 1.73 m(2), and 80.1 [95% CI, 76.7–83.5] g/m(2) for eGFR 45–59 mL/min per 1.73 m(2) compared with 78.7 [95% CI, 75.3–82.1] g/m(2) for eGFR 75–89 mL/min per 1.73 m(2); trend P<0.001). Regarding LV size and function, significant differences were observed for some parameters, particularly at eGFR <30 mL/min per 1.73 m(2). For ACR, the associations remained significant for most parameters (eg, LV mass index, 91.5 [95% CI, 86.6–96.5] g/m(2) for ACR ≥300 mg/g and 82.9 [95% CI, 79.4–86.3] g/m(2) for ACR 30–299 mg/g compared with 77.7 [95% CI, 74.4–81.1] g/m(2) for ACR <10 mg/g [trend P<0.001]; left arterial volume index, 24.9 [95% CI, 22.9–26.8] and 24.7 [95% CI, 23.4–26.1] mL/m(2) compared with 23.4 [95% CI, 22.1–24.7] mL/m(2), respectively [trend P=0.010]). Dichotomizing echo parameters with clinical thresholds, the stronger relationships of ACR over eGFR were further evident. CONCLUSIONS: LV mass was related to both CKD measures, whereas LV size and function were robustly associated with albuminuria. These results have implications for pathophysiological processes behind cardiorenal syndrome and targeted cardiac assessment in patients with CKD. John Wiley and Sons Inc. 2017-09-22 /pmc/articles/PMC5634280/ /pubmed/28939714 http://dx.doi.org/10.1161/JAHA.117.006259 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Matsushita, Kunihiro
Kwak, Lucia
Sang, Yingying
Ballew, Shoshana H.
Skali, Hicham
Shah, Amil M.
Coresh, Josef
Solomon, Scott
Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
title Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
title_full Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
title_fullStr Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
title_full_unstemmed Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
title_short Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
title_sort kidney disease measures and left ventricular structure and function: the atherosclerosis risk in communities study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634280/
https://www.ncbi.nlm.nih.gov/pubmed/28939714
http://dx.doi.org/10.1161/JAHA.117.006259
work_keys_str_mv AT matsushitakunihiro kidneydiseasemeasuresandleftventricularstructureandfunctiontheatherosclerosisriskincommunitiesstudy
AT kwaklucia kidneydiseasemeasuresandleftventricularstructureandfunctiontheatherosclerosisriskincommunitiesstudy
AT sangyingying kidneydiseasemeasuresandleftventricularstructureandfunctiontheatherosclerosisriskincommunitiesstudy
AT ballewshoshanah kidneydiseasemeasuresandleftventricularstructureandfunctiontheatherosclerosisriskincommunitiesstudy
AT skalihicham kidneydiseasemeasuresandleftventricularstructureandfunctiontheatherosclerosisriskincommunitiesstudy
AT shahamilm kidneydiseasemeasuresandleftventricularstructureandfunctiontheatherosclerosisriskincommunitiesstudy
AT coreshjosef kidneydiseasemeasuresandleftventricularstructureandfunctiontheatherosclerosisriskincommunitiesstudy
AT solomonscott kidneydiseasemeasuresandleftventricularstructureandfunctiontheatherosclerosisriskincommunitiesstudy